Historical

CLSI MM3-A2

Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline

Nucleic acid methods for the detection and characterization of microorganisms in clinical specimens are now firmly established in laboratory medicine. These methods offer opportunities for clinical laboratories to provide more rapid and accurate results, and have changed the practice of clinical microbiology and infectious diseases. Clinical and Laboratory Standards Institute (CLSI) document MM3-A2-Molecular Diagnostic Methods for Infectious Diseases; Approved Guideline-Second Edition addresses topics relating to clinical applications, amplified and nonamplified nucleic acid methods, selection and qualification of nucleic acid sequences, establishment and evaluation of test performance characteristics, inhibitors, and interfering substances, controlling false-positive reactions, reporting and interpretation of results, quality assurance, regulatory issues, and recommendations for manufacturers and clinical laboratories.

CONTENT PROVIDER
Clinical And Laboratory Standards Institute [clsi]

Others Also Bought
Establishing Molecular Testing in Clinical Laboratory Environments; Approved Guideline
BS EN ISO 14971 and BS EN 980 - Historical Package (British Standard)
Stability testing of in vitro diagnostic reagents (British Standard)
Included in Packages
This standard is not included in any packages.
Document History
Revised By:
Amendments & Corrections
We have no amendments or corrections for this standard.